Press Release Hub logo
  • Submit a Release
  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Health

Results: 97-108 of 8078

PR Newswire associated0

Healinno Tech Introduces AI-Powered Waterjet Surgical Robot for Minimally Invasive Urology

Chiesi Global Rare Diseases and Protalix BioTherapeutics Announce European Commission Approval of Additional Dosing Regimen of Every Four Weeks for Elfabrio® (pegunigalsidase alfa) ▼

Court Authorizes Notice of Proposed Class Action Settlement for Farmers, Landscapers and Others Exposed to Weed Killers

Sectra showcases MCP-powered AI innovations to accelerate enterprise imaging at HIMSS

Business Wire logo

Galderma Introduces Cetaphil AM/PM Antioxidant Serums, a New Science-Driven Defense and Recovery System for Sensitive Skin

PR Newswire associated0

LOTTE Biologics to Participate in DCAT Week 2026 in New York to Explore Global Partnership Opportunities

PR Newswire associated0

U.S. Patient with Advanced Lung Cancer Stabilized by Novel Immunotherapy Treatment in China

Business Wire logo

Incyte Announces the European Commission Approval of Zynyz® (retifanlimab) for the First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)

Lone Star Funds Announces Agreement to Acquire the Capsules & Health Ingredients Division of Lonza Group AG

PR Newswire associated0

WHO Foundation announces collaboration with Lilly to strengthen health systems for obesity care

Orexo changes the organizational structure and management team to increase focus on development of new products

PR Newswire associated0

Servier and Day One Biopharmaceuticals announce acquisition to expand Servier's rare oncology portfolio

  • Prev Page
  • 1
  • 2
  • …
  • 8
  • 9
  • 10
  • …
  • 673
  • 674
  • Next Page

Pages

  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Press Release Hub

  • Our Services
  • Submit a Release

Websites

  • PA Media Group
  • PA Mediapoint
  • Distribution Packages

© PA Media Group. 2026

Terms of Use

Privacy Policy

Contact Us